Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TKNO | US
0.21
4.98%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
10/09/2024
4.43
4.27
4.49
4.00
Alpha Teknova Inc. produces critical reagents for the research discovery development and commercialization of novel therapies vaccines and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation resuspension and purification. It serves life sciences market including pharmaceutical and biotechnology companies contract development and manufacturing organizations in vitro diagnostic franchises and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister California.
View LessLow Market Beta (-0.4 to 0.8)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
85.7%1 month
112.2%3 months
141.7%6 months
116.0%-
-
3.10
0.39
0.27
-6.23
7.36
-
-23.44M
219.40M
219.40M
-
-53.05
-
-16.60
-41.51
0.24
1.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.46
Range1M
2.00
Range3M
4.30
Rel. volume
0.40
Price X volume
462.50K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Procaps Group S.A. Ordinary Shares | PROC | Drug Manufacturers-Specialty & Generic | 1.8825 | 209.19M | 0.00% | 3.80 | 0.00% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 4.84 | 162.86M | 1.89% | 19.08 | 241.85% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.53 | 143.82M | -0.98% | n/a | -113.78% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 2.09 | 138.84M | 5.03% | n/a | 1.07% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.873 | 132.45M | 0.37% | n/a | 36.36% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.9341 | 128.88M | -2.66% | n/a | -294.40% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.24 | 127.23M | -3.13% | n/a | 30.76% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.127 | 124.67M | -0.78% | n/a | 1.10% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.43 | 119.45M | -3.38% | n/a | 8.14% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7249 | 86.82M | -1.41% | n/a | -148.05% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.03 | 212.02M | 6.77% | 9.28 | 15.44% |
Unifi Inc | UFI | Textile Manufacturing | 6.58 | 121.88M | -1.64% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 42.5 | 117.94M | -4.56% | 8.22 | 71.47% |
Culp Inc | CULP | Textile Manufacturing | 5.45 | 71.60M | -0.18% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3 | 26.92M | -6.50% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.16 | 20.78M | -5.69% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.65 | 15.89M | -8.84% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.65 | 9.08M | -3.59% | n/a | 422.08% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.29 | 3.57M | -15.69% | n/a | 9.62% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3574 | 3.31M | -2.24% | n/a | 19.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -6.23 | - | Cheaper |
Ent. to Revenue | 7.36 | - | Cheaper |
PE Ratio | - | 28.13 | - |
Price to Book | 3.10 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 141.69 | - | Riskier |
Debt to Equity | 0.39 | -0.91 | Expensive |
Debt to Assets | 0.27 | 0.45 | Cheaper |
Market Cap | 219.40M | - | Emerging |